SweetValueLab
Write for us

Altria vs Philip Morris MO vs PM

Altria and Philip Morris on one sheet: valuation multiples, growth, margins, debt, dividends and returns, each section labelled with the period it covers, from the companies' filings. Add or remove a stock above the sheet; the link holds the set.

Compare other stocks
MOPM

What differs most

generated from the numbers below
  • Market value: Philip Morris $314.64B, Altria $122.93B.
  • Free-cash-flow yield: Altria 7.4%, Philip Morris 3.4%.
  • Trailing P/E: Philip Morris 29.5×, Altria 15.5×.
  • One-year price return: Philip Morris +28.1%, Altria +13.8%.

Price return

2025-10-26 → 2026-10-26
MO+13.8%
PM+28.1%
-20%0%20%40%2025-10-242026-04-272026-10-26
Prices at the close on 2026-10-26
MO
Altria
$73.62

Profile

latest
Sector
Consumer Defensive
Consumer Defensive
Industry
Tobacco
Tobacco
Market value
$122.93B
$314.64B
Enterprise value
$145.14B
$355.52B
Employees
5,900
84,900
Revenue per employee (TTM)
$3.6M
$508K

Our models

nightlythe valuation on each stock's page
Price vs model
31% undervalued vs model
21% overvalued vs model
Model range
$61.91–250
$92.20–411
Models in the headline
1
1
FCF growth priced in, at a 10% return
5.2%
19.1%
Every model, its assumptions and its range: MO valuation · PM valuation. The growth priced in, at any return: MO reverse DCF · PM reverse DCF.

Trading

close 2026-10-26
Last close
$73.62
$201.87
52-week high
$76.07
$205.58
52-week low
$54.72
$144.33
Price vs 52-week high
−3.2%
−1.8%
Price vs 52-week low
+34.5%
+39.9%
Average daily volume / shares
0.5%
0.3%
Beta
0.46
0.36

Returns

to 2026-10-26
1 month
+7.0%
+6.0%
3 months
+0.9%
+4.6%
6 months
+10.1%
+22.9%
Year to date
+27.7%
+25.9%
1 year
+13.8%
+28.1%
1 year, dividends added
+20.5%
+31.9%
2 years
+48.1%
+55.5%

Valuation

MO price × TTM to Jun 2026 · PM price × TTM to Sep 2026
P/E (TTM)
15.5×
29.5×
P/E on consensus EPS (next FY)
13.0×
24.2×
Price / sales
5.8×
7.3×
EV / sales
6.9×
8.2×
EV / EBITDA
12.3×
17.8×
Price / book
—
—
Price / free cash flow (FY)
13.5×
29.5×
Free-cash-flow yield (FY)
7.4%
3.4%

Growth

TTM and FY2025
Revenue growth (TTM)
—
—
Revenue growth, consensus next FY
+2.0%
+7.0%
Revenue, 3-year CAGR
−0.9%
8.6%
Revenue, 5-year CAGR
−0.7%
7.2%
EPS growth (TTM)
—
—
EPS growth, consensus next FY
+38.2%
+15.0%
EPS, 3-year CAGR
8.8%
7.7%
Free cash flow, 3-year CAGR
4.1%
3.1%
Diluted shares, 3-year change
−7.0%
+0.4%

Profitability

MO TTM to Jun 2026 · PM TTM to Sep 2026
Gross margin (FY)†
72.2%
67.1%
Operating margin
58.0%
38.5%
EBITDA margin
55.9%
46.4%
Net margin
37.8%
24.8%
Free-cash-flow margin (FY)
45.1%
26.2%
Return on equity
—
—
Return on assets
23.9%
16.0%
Asset turnover
0.63
0.65
† Gross margin (FY): As filed. Companies draw the cost-of-revenue line in different places, so gross margins of two companies in one industry can differ for that reason alone; operating margin does not depend on where the line is drawn.

Balance sheet

MO MRQ Jun 2026 · PM MRQ Sep 2026
Cash
$2.37B
$6.68B
Total debt
$24.58B
$47.56B
Net debt
$22.21B
$40.88B
Debt / equity
—
—
Net debt / EBITDA (TTM)
1.9×
2.0×
Interest coverage (FY)
10.2×
9.4×
Current ratio (FY)
0.61
0.96

Dividends

trailing 12 months
Dividend yield
5.8%
3.0%
Dividends per share
$4.29
$6.01
Payout ratio (of TTM EPS)
90.5%
87.9%
Dividend per share, 5-year CAGR
4.3%
4.4%
Frequency
Quarterly
Quarterly

Ownership and activity

last 90 days · latest 13F
Tracked superinvestors holding (13F)
6
11
Insider open-market buys (Form 4)
$101K
$0
Insider sales (Form 4)
$0
$0
Analyst upgrades
0
0
Analyst downgrades
0
0

Statements

MO income TTM to Jun 2026 · cash flow FY2025 · PM income TTM to Sep 2026 · cash flow FY2025
Revenue
$21.11B
$43.14B
EBITDA
$11.80B
$20.01B
Operating income
$12.26B
$16.62B
Net income
$7.97B
$10.71B
EPS (diluted)
$4.74
$6.84
Operating cash flow
$9.29B
$12.23B
Capital expenditure
−$216.0M
−$1.57B
Free cash flow
$9.07B
$10.66B
Dividends paid
$6.96B
$8.62B

Keep comparing

the matchups people search for

Statements, prices, dividends and consensus estimates from Financial Modeling Prep; insider trades from Form 4 and holdings from 13F. Refreshed nightly. A comparison of filed numbers, not a recommendation to buy, sell or hold any security.